Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diphenhydramine + acetaminophen is an oral combination drug containing two active ingredients: - **Acetaminophen** is a non-opioid analgesic and antipyretic that reduces fever and relieves mild to moderate pain by inhibiting prostaglandin synthesis in the central nervous system. - **Diphenhydramine** is a first-generation antihistamine that acts as an antagonist at histamine H1 receptors. It provides relief from allergy symptoms and also has sedative properties due to its ability to cross the blood-brain barrier. This combination is primarily used for short-term management of occasional insomnia associated with minor aches and pains (such as headache, back pain, joint or muscle pain), as well as for relief of cold or allergy symptoms like runny nose or sneezing when accompanied by discomfort. It should not be used solely for sleep problems without pain[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diphenhydramine + acetaminophen.